Join 350,000+ marketers who rely on MarketingProfs for B2B know-how every day. Get your B2B news delivered directly to your inbox, 4x a week with the MarketingProfs Today newsletter. Frustrated by ...
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...
Borregaard employees have been given the opportunity to buy shares at a discounted price. The offer is valid from 3 February up to and including 7 February 2025. The price per share will be equal to ...